Abstract:Highlights • Gd/MPC inherits active targeting tumor microenvironment capacity of homologous cancer cell membrane. • Gd/MPC realizes efficient delivery and controlled release of aPD-1 based on aperture of MOF, coating of cell membrane, encapsulation of phase change material. • Gd/MPC realizes microwave thermal therapy-augmented cancer immunotherapy. The clinical application of cancer immunotherapy is unsatisfied due to low response rates and systemic immune-related adverse events. Microwave hyperthermia can be used as a synergistic immunotherapy to amplify the antitumor effect. Herein, we designed a Gd-based metal-organic framework (Gd-MOF) nanosystem for MRI-guided thermotherapy and synergistic immunotherapy, which featured high performance in drug loading and tumor tissue penetration. The PD-1 inhibitor (aPD-1) was initially loaded in the porous Gd-MOF (Gd/M) nanosystem. Then, the phase change material (PCM) and the cancer cell membrane were further sequentially modified on the surface of Gd/MP to obtain Gd-MOF@aPD-1@CM (Gd/MPC). When entering the tumor microenvironment (TME), Gd/MPC induces immunogenic death of tumor cells through microwave thermal responsiveness, improves tumor suppressive immune microenvironment and further enhances anti-tumor ability of T cells by releasing aPD-1. Meanwhile, Gd/MPC can be used for contrast-enhanced MRI. Transcriptomics data revealed that the downregulation of MSK2 in cancer cells leads to the downregulation of c-fos and c-jun, and ultimately leads to the apoptosis of cancer cells after treatment. In general, Gd/MPC nanosystem not only solves the problem of system side effect, but also achieves the controlled drug release via PCM, providing a promising theranostic nanoplatform for development of cancer combination immunotherapy. Graphical abstract GdMOF@aPD-1@CM(Gd/MPC) shows unique anti-tumor advantages. Based on the aperture of MOF, the coating of cell membrane, and the encapsulation of phase change material (1-tetracyteol), it not only realizes the efficient delivery and controlled release of aPD-1, but also achieves the synergistic effect of microwave hyperthermia and immunotherapy. Download : Download high-res image (307KB) Download : Download full-size image

A two-stage exacerbated hypoxia nanoengineering strategy induced amplifying activation of Tirapazamine for microwave hyperthermia – chemotherapy of breast cancer

Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

A multifunctional nanoplatform for improving microwave hyperthermia by a combination therapy of vessel disruptive agent and immune modulator

A two-pronged strategy to alleviate tumor hypoxia and potentiate photodynamic therapy by mild hyperthermia

Engineering liquid metal-based nanozyme for enhancing microwave dynamic therapy in breast cancer PDX model

AIPH‐Encapsulated Thermo‐Sensitive Liposomes for Synergistic Microwave Ablation and Oxygen‐independent Dynamic Therapy

Enhanced Tumor Synergistic Therapy by Injectable Magnetic Hydrogel Mediated Generation of Hyperthermia and Highly Toxic Reactive Oxygen Species.

Enhanced tumor penetration for efficient chemotherapy by a magnetothermally sensitive micelle combined with magnetic targeting and magnetic hyperthermia

Microwave-responsive gadolinium metal-organic frameworks nanosystem for MRI-guided cancer thermotherapy and synergistic immunotherapy

PLGA Nanoparticles Loaded with Sorafenib Combined with Thermosensitive Hydrogel System and Microwave Hyperthermia for Multiple Sensitized Radiotherapy

TME-Responsive Nanoplatform with Glutathione Depletion for Enhanced Tumor-Specific Mild Photothermal/Gene/Ferroptosis Synergistic Therapy

Mesothelin Targeted Nano-System Enhanced Chemodynamic Therapy and Tirapazamine Chemotherapy Via Lactate Depletion

GSH‐Depleted Nanozymes with Hyperthermia‐Enhanced Dual Enzyme‐Mimic Activities for Tumor Nanocatalytic Therapy

Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment

Synergistic microwave hyperthermia treatment for subcutaneous deep in situ breast cancer using conformal array antennas and a microwave-thermal-sensitive nanomaterial

Biomimetic cell membrane-coated glucose/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy

Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors

Mitochondrial-uncoupling nanomedicine for self-heating and immunometabolism regulation in cancer cells

Microwave Hyperthermia Enhances the Sensitivity of Lung Cancer Cells to Gemcitabine Through Reactive Oxygen Species‑induced Autophagic Death.

Targeted Heating of Mitochondria Greatly Augments Nanoparticle-Mediated Cancer Chemotherapy